Because Angelman syndrome is caused by the LoF mutations in maternal UBE3A, hippocampal injection of an AAV9 delivering the UBE3A gene has been used as a gene therapy in AS mice, where it was found to markedly improve associative learning (Daily et al., 2011). Here, UBE3A is linked to Angelman syndrome.